What renal anomalies are associated with Turner syndrome and what are the recommended screening and management strategies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Turner Syndrome and Renal Anomalies

All patients with Turner syndrome should undergo renal ultrasonography at the time of diagnosis to screen for structural kidney abnormalities, which occur in approximately 30% of cases. 1

Renal Anomalies Associated with Turner Syndrome

The most common renal malformations in Turner syndrome include:

  • Horseshoe kidney (most frequent structural anomaly)
  • Collecting system malformations (duplication of collecting system, hydronephrosis)
  • Renal malrotation and positional abnormalities
  • Multicystic dysplastic kidney
  • Renal agenesis or hypoplasia

The frequency of renal anomalies ranges from 17-30% across studies 2, 3, 4, 5. Importantly, patients with the nonmosaic 45,X karyotype have a significantly higher prevalence of renal malformations (approximately 51%) compared to those with mosaic or structural X chromosome abnormalities (approximately 22%) 4.

Screening Strategy

At Diagnosis

Perform renal ultrasonography immediately upon diagnosis of Turner syndrome, regardless of age or presence of symptoms 1. This is critical because approximately 80% of renal and cardiovascular anomalies are asymptomatic and only detected through routine screening after Turner syndrome diagnosis 5.

Ongoing Surveillance

  • If initial ultrasound is normal: No routine repeat imaging is required unless clinical symptoms develop (urinary tract infections, hypertension, or abnormal urinalysis)
  • If renal anomalies are detected: Establish nephrology follow-up for monitoring of potential complications

Management Considerations

Key Clinical Implications

Monitor for secondary complications in patients with detected renal anomalies:

  • Hypertension: More common in patients with structural renal malformations 4
  • Recurrent urinary tract infections: Particularly in those with collecting system abnormalities 4
  • Renal function decline: Though uncommon, can progress to end-stage renal disease requiring transplantation 6

Important Caveats

Renal ultrasonography may underestimate the true frequency of renal malformations 3. While ultrasound effectively detects anatomical abnormalities, renal scintigraphy can identify early functional abnormalities in up to 44% of patients, including subnormal glomerular filtration rate and abnormal perfusion patterns 2. However, scintigraphy is not routinely recommended as first-line screening due to radiation exposure and cost considerations.

Growth hormone therapy considerations: In patients on growth hormone treatment who develop renal cysts, consider the potential association between growth hormone and cyst proliferation, though this remains an area requiring further study 7.

Cardiovascular Screening Integration

Because renal screening occurs at diagnosis, coordinate with mandatory cardiovascular evaluation using transthoracic echocardiography and cardiac MRI to assess for bicuspid aortic valve (15-30%), aortic coarctation (7-18%), and ascending aortic dilation (33%) 1. These cardiovascular anomalies are more common than renal abnormalities and represent the leading cause of mortality in Turner syndrome.

Karyotype-Specific Risk

Patients with 45,X karyotype warrant heightened vigilance for both structural renal anomalies and functional abnormalities compared to mosaic forms 2, 4. This should inform the intensity of initial screening and threshold for nephrology referral.

References

5
Research

Cardiovascular and renal anomalies in Turner syndrome.

Revista da Associacao Medica Brasileira (1992), 2010

7
Research

Turner syndrome and autosomal dominant polycystic kidney disease.

Proceedings (Baylor University. Medical Center), 2020

Related Questions

In a 14‑year‑old female diagnosed with Turner syndrome who presents with short stature, what is Turner syndrome, what physical findings are expected on examination, and what chromosomal anomaly underlies it?
What is Turner syndrome?
What are the anesthesia considerations for a patient with Turner syndrome?
What are the mechanisms underlying diabetes in Turner syndrome and which comorbidities should be monitored?
Why does the answer discuss Down syndrome (trisomy 21) when I asked about Turner syndrome (monosomy X)?
Does olanzapine decrease blood pressure and heart rate?
What are the types of cataracts?
Can amiodarone be administered to a patient receiving a norepinephrine infusion?
What is the recommended treatment for cataracts?
What are the pharmacokinetics of Rexulti (brexpiprazole) and what are the Food and Drug Administration (FDA) indications?
Is amiodarone appropriate for treating frequent premature ventricular contractions (PVCs) causing bigeminy in an adult patient without structural heart disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.